Co-Diagnostics
CODX
38 hedge funds and large institutions have $4.89M invested in Co-Diagnostics in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 14 reducing their positions, and 9 closing their positions.
145% more call options, than puts
Call options by funds: $108K | Put options by funds: $44K
1.38% less ownership
Funds ownership: 15.33% → 13.95% (-1.4%)
16% less funds holding
Funds holding: 45 → 38 (-7)
22% less capital invested
Capital invested by funds: $6.25M → $4.89M (-$1.36M)
57% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 14
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAS
SMI Advisory Services
Columbus,
Indiana
|
+$24.9K |
| 2 |
GS
GTS Securities
Miami,
Florida
|
+$15.2K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$12.7K |
| 4 |
KAS
Kestra Advisory Services
Austin,
Texas
|
+$12.5K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$6.63K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$118K |
| 2 |
KOC
Koss-Olinger Consulting
Gainesville,
Florida
|
-$78K |
| 3 |
Man Group
London,
United Kingdom
|
-$76.6K |
| 4 |
Jane Street
New York
|
-$63.1K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$28.7K |
CODX Hedge Fund Activity: Q1 2024 in Review
38 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q1 2024, worth a combined $4.89M — down 22% from $6.25M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of CODX and 2 opened new positions — a net loss of 7 holders — while 14 trimmed existing stakes and 6 added.
The largest buyer was SMI Advisory Services, adding an estimated $24.9K. The largest seller was Bank of Montreal, exiting entirely with an estimated $118K sold.
- 38 institutional investors held Co-Diagnostics (CODX) as of Q1 2024, down from 45 in Q4 2023.
- Funds reported $4.89M of Co-Diagnostics stock for Q1 2024, down 22% quarter-over-quarter.
- 2 funds opened new Co-Diagnostics positions in Q1 2024 and 9 closed out, a net change of -7 holders.
- The largest Co-Diagnostics buyer in Q1 2024 was SMI Advisory Services, an estimated $24.9K added.
- The largest Co-Diagnostics seller in Q1 2024 was Bank of Montreal, an estimated $118K sold.
Based on aggregated 13F filings for Q1 2024.